Group 1 - Jinguang Electric won a bid for a State Grid procurement project with a total amount of 21.7976 million yuan, accounting for approximately 2.93% of the company's expected revenue for 2024 [1] - Shen Gong Co. plans to reduce its shareholding by up to 2%, equating to 340.61 million shares [2] - Guomai Culture received a government subsidy of 3.78 million yuan, representing 24.90% of its audited net profit for 2024 [2] Group 2 - Guomai Culture focuses on the development and provision of digital content operation platforms [3] - Shentong Technology's two directors plan to collectively reduce their shareholding by no more than 0.0473% [4] - Ruihua Tai intends to reduce its shareholding by up to 1%, amounting to 1.8 million shares [5] Group 3 - Guoji Automobile's wholly-owned subsidiary won a total contract project worth 809 million yuan [7] - Changcheng Technology's stock is expected to remain suspended due to potential changes in control [9] - Huabei Pharmaceutical's subsidiary received approval for a chemical raw material drug listing application [11] Group 4 - Fuyao Glass has changed its legal representative to Cao Hui [13] - Huaxi Biological plans to reduce its shareholding by up to 2%, totaling 9.6336 million shares [14] - Hopu Co. signed a procurement contract for a storage system worth 500 million yuan [15] Group 5 - ST Songfa's subsidiary plans to invest 458 million yuan in a mooring dock project [18] - Zhonghong Medical's subsidiary is expected to be selected for several centralized procurement projects [19] - Huakai Yibai's vice chairman plans to increase his shareholding by no less than 30 million yuan [20] Group 6 - Haichuang Pharmaceutical completed the first participant enrollment for a clinical trial of a drug for metabolic-associated fatty liver disease [21] - Dongfang Biological's subsidiary obtained medical device product registration certificates for multiple products [22] - Lepu Medical's rechargeable implantable deep brain stimulation system received NMPA registration approval [23] Group 7 - Changyuan Power's power generation in October decreased by 32.25% year-on-year [24] - Jinshi Yaya's diclofenac sodium sustained-release tablets passed the consistency evaluation for generic drugs [26] - Yutong Bus sold 3,040 buses in October, a decrease of 5.62% year-on-year [27] Group 8 - Far East Co. signed contracts worth 1.062 billion yuan in October [28] - Tianya Pharmaceutical's subsidiary passed the consistency evaluation for a drug [29] - Yuheng Pharmaceutical plans to resolve a debt dispute through a share transfer agreement [30] Group 9 - Hailanxin's subsidiary won a bid for a marine observation network project worth 1.097 billion yuan [31] - Huasheng Lithium plans to reduce its shareholding by up to 0.37% [33] - Maike Biological obtained product registration certificates for five new in vitro diagnostic products [34] Group 10 - Huayuan New Materials signed a strategic cooperation agreement with Taiblue New Energy [37] - Greebo's actual controller and some directors plan to collectively increase their shareholding by no less than 11.5 million yuan [39] - Yian Technology received a government subsidy of 1.1643 million yuan [41] Group 11 - Kangtai Biological's quadrivalent influenza virus vaccine has commenced Phase I clinical trials [43] - Spring Airlines received a commitment letter for a stock repurchase loan of up to 450 million yuan [45] - Foton Motor sold 8,006 new energy vehicles in October, a year-on-year increase of 98.83% [46] Group 12 - Greebo plans to transfer 100% equity of its subsidiary for 280 million yuan [48] - Siwei Liekong's director is under investigation [49] - Dingyang Technology launched a new generation of multi-channel microwave signal generator products [50] Group 13 - Jiangling Motors reported a year-on-year increase of 8.06% in vehicle sales for October [51] - Shengyi Technology plans to reduce its shareholding by up to 1.03% [52] - Dongshan Precision completed the acquisition of 100% equity of France's GMD Group for approximately 814 million yuan [53] Group 14 - Tianyang Technology plans to acquire 7.5% of Baoland's shares for 155 million yuan [54] - Alter plans to establish a joint venture company with a total investment of 672 million yuan [54] - Changchun High-tech's clinical trial application for a drug was approved [55] Group 15 - Beibu Gulf Port's cargo throughput in October increased by 22.73% year-on-year [56] - ST Zhangjiajie was ruled by the court to undergo reorganization [57] - Teda Co.'s subsidiary was selected as a supplier for an energy project in Indonesia [58]

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-047 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 减持计划的主要内容 航科新世纪拟通过集中竞价方式减持数量合计不超过 1,800,002 股（不超过 公司总股本比例 1.0000%）。本次减持计划自本公告披露之日起 15 个交易日之后 的 3 个月内实施。 上述股份减持价格按市场价格确定，若减持期间公司有派息、送股、资本公 积金转增股本、配股等除权除息事项，减持计划将进行相应调整。 公司于近日收到股东航科新世纪出具的《关于股份减持计划的告知函》，现 将相关减持计划公告如下： | 股东名称 | 航科新世纪科技发展（深圳）有限公司 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | ...

Company Summary - Ruihua Tai (SH 688323) announced that Hangke New Century Technology Development (Shenzhen) Co., Ltd. holds approximately 42.08 million shares, accounting for about 23.38% of the total share capital [1] - The shares held by Hangke New Century were acquired before the initial public offering and will be released from restrictions and available for trading starting April 29, 2024 [1] - Hangke New Century plans to reduce its holdings by no more than approximately 1.8 million shares through centralized bidding within three months after the announcement date [1] - For the year 2024, Ruihua Tai's revenue composition is 99.15% from rubber and plastic products, with other businesses contributing 0.85% [1] Industry Summary - Ruihua Tai's market capitalization is currently 2.6 billion yuan [2] - There has been a significant increase in overseas orders for a related industry, with a 246% rise covering over 50 countries and regions [2] - Industry entrepreneurs have raised concerns about potential malicious competition, as some entities are reportedly selling at a loss [2]

格隆汇11月4日丨瑞华泰(688323.SH)公布，航科新世纪拟通过集中竞价方式减持数量合计不超过180万 股（不超过公司总股本比例1.0000%）。本次减持计划自本公告披露之日起15个交易日之后的3个月内 实施。上述股份减持价格按市场价格确定。 ...

瑞华泰11月4日公告，公司股东航科新世纪科技发展（深圳）有限公司拟通过集中竞价方式减持公司股 份不超过1,800,002股，即不超过公司总股本的1%。上述股份减持价格按市场价格确定，若减持期间公 司有派息、送股、资本公积金转增股本、配股等除权除息事项，减持计划将进行相应调整。 ...

人民财讯11月4日电，瑞华泰(688323)11月4日公告，持股23.38%的股东航科新世纪拟通过集中竞价方式 减持所持有的公司股份不超过180万股(占公司总股本的1%)。 ...

智通财经APP讯，瑞华泰(688323.SH)发布公告，航科新世纪拟通过集中竞价方式减持数量合计不超过 180万股(不超过公司总股本比例1%)。本次减持计划自公告披露之日起15个交易日之后的3个月内实施。 ...

瑞华泰公告，航科新世纪拟通过集中竞价方式减持数量合计不超过1,800,002 股（不超过公司总股本比 例 1.0000%）。本次减持计划自本公告披露之日起15 个交易日之后的 3 个月内实施。 ...

Core Viewpoint - 瑞华泰 (688323.SH) announced that航科新世纪 plans to reduce its holdings by a total of no more than 1.8 million shares, which accounts for up to 1% of the company's total share capital [1] Summary by Category - **Reduction Plan**: The reduction plan will be implemented through centralized bidding and will take place within three months after the announcement, starting 15 trading days from the disclosure date [1]

与此同时，深能环保电厂项目、停车场等三个重点公辅配套项目也同步开工，为园区产业发展和项目落 地提供基础保障。 11月3日，深汕高端电子化学品产业园迎来多个产业项目及公辅配套项目集中开工与入园，园区建设进 入全面提速阶段。作为深圳首家、华南地区唯一的高端电子化学品专业园区，其建设推进将为粤港澳大 湾区电子化学品产业高质量发展注入新动能。 当日上午，位于深汕特别合作区鹅埠街道的产业园现场一派繁忙。4个产业项目、3个公辅配套项目正式 动工，另有2个配套项目同步入园，掀起园区建设新高潮。此次集中开工的产业项目涵盖高端制造、半 导体新材料等战略性新兴产业。其中，由深圳瑞华泰应用材料科技有限公司投资的聚酰亚胺新材料工业 园项目，总投资达10亿元，预计于2027年8月建成并进入设备调试与试产阶段，将有力提升高性能聚酰 亚胺材料的产业链竞争力与安全性，推动关键材料国产化进程。 深圳瑞华泰薄膜科技股份有限公司董事会秘书李涛表示，公司将全力推进项目建设，确保按期竣工并尽 快达产；中期目标为深度融入合作区产业生态，与区内优秀企业展开合作。他指出，该项目聚焦聚酰亚 胺材料产业链的深耕拓展，产品终端应用于高清显示、半导体、新能源及航天 ...